(BUD) Anheuser Busch Inbev - Ratings and Ratios
Exchange: NYSE •
Country: Belgium •
Currency: USD •
Type: Common Stock •
ISIN: US03524A1088
Beer, Spirits, Canned, Non-Alcoholic
Dividends
| Dividend Yield | 2.03% |
| Yield on Cost 5y | 1.89% |
| Yield CAGR 5y | 11.62% |
| Payout Consistency | 89.8% |
| Payout Ratio | 34.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 21.7% |
| Value at Risk 5%th | 33.5% |
| Relative Tail Risk | -6.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 9.25 |
| CAGR/Max DD | 0.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.554 |
| Beta | 0.249 |
| Beta Downside | 0.160 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| Mean DD | 9.67% |
| Median DD | 8.98% |
Description: BUD Anheuser Busch Inbev December 02, 2025
Anheuser-Busch InBev (NYSE:BUD) is a global brewer headquartered in Leuven, Belgium, with a portfolio of roughly 500 brands-including Budweiser, Corona Extra, Stella Artois, and Michelob Ultra-sold across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. The company also markets spirits-based ready-to-drink and non-alcoholic beverages.
Key metrics as of FY 2023: revenue of $57 billion, adjusted EBITDA margin of 18 %, and net debt-to-EBITDA of 3.2×, reflecting a balance-sheet still leveraged after the 2022-23 debt-reduction program. Growth is being driven by premiumization (e.g., higher-margin craft and imported brands), a 7 % increase in on-trade volume in emerging markets, and a 4 % rise in e-commerce sales of RTD products, while commodity price volatility and shifting consumer preferences toward low-alcohol options remain material risks.
For a deeper, data-rich analysis of BUD’s valuation dynamics, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (6.10b TTM) > 0 and > 6% of Revenue (6% = 3.52b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -17.18% (prev -49.68%; Δ 32.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 15.20b > Net Income 6.10b (YES >=105%, WARN >=100%) |
| Net Debt (61.00b) to EBITDA (15.54b) ratio: 3.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.99b) change vs 12m ago -2.79% (target <= -2.0% for YES) |
| Gross Margin 55.91% (prev 43.72%; Δ 12.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.52% (prev 27.08%; Δ 0.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.23 (EBITDA TTM 15.54b / Interest Expense TTM 5.03b) >= 6 (WARN >= 3) |
Altman Z'' 1.49
| (A) -0.05 = (Total Current Assets 23.00b - Total Current Liabilities 33.07b) / Total Assets 206.64b |
| (B) 0.23 = Retained Earnings (Balance) 46.58b / Total Assets 206.64b |
| (C) 0.05 = EBIT TTM 11.23b / Avg Total Assets 212.99b |
| (D) 0.68 = Book Value of Equity 80.67b / Total Liabilities 117.94b |
| Total Rating: 1.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.26
| 1. Piotroski 4.50pt |
| 2. FCF Yield 6.25% |
| 3. FCF Margin 19.90% |
| 4. Debt/Equity 0.79 |
| 5. Debt/Ebitda 3.92 |
| 6. ROIC - WACC (= 0.38)% |
| 7. RoE 7.19% |
| 8. Rev. Trend 30.89% |
| 9. EPS Trend 51.26% |
What is the price of BUD shares?
As of December 03, 2025, the stock is trading at USD 61.64 with a total of 1,236,267 shares traded.
Over the past week, the price has changed by -1.45%, over one month by +1.00%, over three months by +0.64% and over the past year by +16.06%.
Over the past week, the price has changed by -1.45%, over one month by +1.00%, over three months by +0.64% and over the past year by +16.06%.
Is BUD a buy, sell or hold?
Anheuser Busch Inbev has received a consensus analysts rating of 4.15.
Therefore, it is recommended to buy BUD.
- Strong Buy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.1 | 25.1% |
| Analysts Target Price | 77.1 | 25.1% |
| ValueRay Target Price | 64.1 | 4% |
BUD Fundamental Data Overview November 26, 2025
Market Cap USD = 121.70b (121.70b USD * 1.0 USD.USD)
P/E Trailing = 20.7309
P/E Forward = 14.9477
P/S = 2.0767
P/B = 1.5103
P/EG = 1.2527
Beta = 0.671
Revenue TTM = 58.61b USD
EBIT TTM = 11.23b USD
EBITDA TTM = 15.54b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 186.50b USD (121.70b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 2.23 (Ebit TTM 11.23b / Interest Expense TTM 5.03b)
FCF Yield = 6.25% (FCF TTM 11.66b / Enterprise Value 186.50b)
FCF Margin = 19.90% (FCF TTM 11.66b / Revenue TTM 58.61b)
Net Margin = 10.41% (Net Income TTM 6.10b / Revenue TTM 58.61b)
Gross Margin = 55.91% ((Revenue TTM 58.61b - Cost of Revenue TTM 25.84b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.90 (Enterprise Value 186.50b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 7.62b (EBIT 11.23b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 3.92 (Net Debt 61.00b / EBITDA 15.54b)
Debt / FCF = 5.23 (Net Debt 61.00b / FCF TTM 11.66b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.95% (Net Income 6.10b / Total Assets 206.64b)
RoE = 7.19% (Net Income TTM 6.10b / Total Stockholder Equity 84.76b)
RoCE = 7.31% (EBIT 11.23b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 5.05% (NOPAT 7.62b / Invested Capital 151.01b)
WACC = 4.67% (E(121.70b)/V(193.87b) * Re(6.93%) + D(72.17b)/V(193.87b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 78.17% ; FCFE base≈11.27b ; Y1≈11.17b ; Y5≈11.66b
Fair Price DCF = 119.5 (DCF Value 206.59b / Shares Outstanding 1.73b; 5y FCF grow -1.57% → 3.0% )
EPS Correlation: 51.26 | EPS CAGR: 2.57% | SUE: 0.41 | # QB: 0
Revenue Correlation: 30.89 | Revenue CAGR: 1.72% | SUE: -0.10 | # QB: 0
EPS next Year (2026-12-31): EPS=4.19 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=+12.4% | Growth Revenue=+5.4%
P/E Trailing = 20.7309
P/E Forward = 14.9477
P/S = 2.0767
P/B = 1.5103
P/EG = 1.2527
Beta = 0.671
Revenue TTM = 58.61b USD
EBIT TTM = 11.23b USD
EBITDA TTM = 15.54b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 186.50b USD (121.70b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 2.23 (Ebit TTM 11.23b / Interest Expense TTM 5.03b)
FCF Yield = 6.25% (FCF TTM 11.66b / Enterprise Value 186.50b)
FCF Margin = 19.90% (FCF TTM 11.66b / Revenue TTM 58.61b)
Net Margin = 10.41% (Net Income TTM 6.10b / Revenue TTM 58.61b)
Gross Margin = 55.91% ((Revenue TTM 58.61b - Cost of Revenue TTM 25.84b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.90 (Enterprise Value 186.50b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 7.62b (EBIT 11.23b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 3.92 (Net Debt 61.00b / EBITDA 15.54b)
Debt / FCF = 5.23 (Net Debt 61.00b / FCF TTM 11.66b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.95% (Net Income 6.10b / Total Assets 206.64b)
RoE = 7.19% (Net Income TTM 6.10b / Total Stockholder Equity 84.76b)
RoCE = 7.31% (EBIT 11.23b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 5.05% (NOPAT 7.62b / Invested Capital 151.01b)
WACC = 4.67% (E(121.70b)/V(193.87b) * Re(6.93%) + D(72.17b)/V(193.87b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 78.17% ; FCFE base≈11.27b ; Y1≈11.17b ; Y5≈11.66b
Fair Price DCF = 119.5 (DCF Value 206.59b / Shares Outstanding 1.73b; 5y FCF grow -1.57% → 3.0% )
EPS Correlation: 51.26 | EPS CAGR: 2.57% | SUE: 0.41 | # QB: 0
Revenue Correlation: 30.89 | Revenue CAGR: 1.72% | SUE: -0.10 | # QB: 0
EPS next Year (2026-12-31): EPS=4.19 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=+12.4% | Growth Revenue=+5.4%
Additional Sources for BUD Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle